- Home
- ITCI vs MASI Comparison
ITCI vs MASI Comparison
Compare ITCI & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- MASI
- Stock Information
- Founded
- ITCI 2002
- MASI 1989
- Country
- ITCI United States
- MASI United States
- Employees
- ITCI N/A
- MASI N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- MASI Medical/Dental Instruments
- Sector
- ITCI Health Care
- MASI Health Care
- Exchange
- ITCI Nasdaq
- MASI Nasdaq
- Market Cap
- ITCI 8.0B
- MASI 8.1B
- IPO Year
- ITCI N/A
- MASI 2007
- Fundamental
- Price
- ITCI $85.60
- MASI $172.96
- Analyst Decision
- ITCI Strong Buy
- MASI Buy
- Analyst Count
- ITCI 12
- MASI 7
- Target Price
- ITCI $97.67
- MASI $167.00
- AVG Volume (30 Days)
- ITCI 771.8K
- MASI 682.1K
- Earning Date
- ITCI 10-30-2024
- MASI 11-05-2024
- Dividend Yield
- ITCI N/A
- MASI N/A
- EPS Growth
- ITCI N/A
- MASI N/A
- EPS
- ITCI N/A
- MASI 1.45
- Revenue
- ITCI $613,728,000.00
- MASI $2,042,600,000.00
- Revenue This Year
- ITCI $48.25
- MASI $4.00
- Revenue Next Year
- ITCI $38.47
- MASI $3.10
- P/E Ratio
- ITCI N/A
- MASI $119.43
- Revenue Growth
- ITCI 46.08
- MASI N/A
- 52 Week Low
- ITCI $58.14
- MASI $91.60
- 52 Week High
- ITCI $93.45
- MASI $174.34
- Technical
- Relative Strength Index (RSI)
- ITCI 55.65
- MASI 78.37
- Support Level
- ITCI $81.83
- MASI $156.53
- Resistance Level
- ITCI $86.36
- MASI $163.30
- Average True Range (ATR)
- ITCI 2.54
- MASI 6.41
- MACD
- ITCI -0.76
- MASI 0.61
- Stochastic Oscillator
- ITCI 31.15
- MASI 94.86
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About MASI Masimo Corporation
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.